Hisanobu Ogata

3.8k total citations · 1 hit paper
26 papers, 3.0k citations indexed

About

Hisanobu Ogata is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Hisanobu Ogata has authored 26 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Hisanobu Ogata's work include interferon and immune responses (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Hisanobu Ogata is often cited by papers focused on interferon and immune responses (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Hisanobu Ogata collaborates with scholars based in Japan, United States and Russia. Hisanobu Ogata's co-authors include Michael Karin, David H. Broide, Hiroyuki Takahashi, Reiko Nishigaki, Guobin He, Maria Hatziapostolou, Takafumi Yoshida, Joan Font-Burgada, Hayato Nakagawa and Ekihiro Seki and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Gastroenterology.

In The Last Decade

Hisanobu Ogata

26 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development

2014 396 citations Hayato Nakagawa, Atsushi Umemura et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hisanobu Ogata Japan	16	1.1k	1.0k	863	755	716	26	3.0k
Debanjan Dhar United States	22	1.2k 1.1×	1.1k 1.1×	883 1.0×	468 0.6×	650 0.9×	32	3.1k
Hayato Hikita Japan	29	1.7k 1.5×	1.4k 1.3×	600 0.7×	723 1.0×	842 1.2×	133	3.6k
Naiara Beraza United Kingdom	31	1.2k 1.0×	995 1.0×	486 0.6×	498 0.7×	549 0.8×	55	2.7k
Atsushi Hosui Japan	25	1.1k 0.9×	721 0.7×	445 0.5×	487 0.6×	497 0.7×	52	2.2k
Joan Font-Burgada United States	15	1.0k 0.9×	587 0.6×	852 1.0×	506 0.7×	493 0.7×	20	2.6k
Asahiro Morishita Japan	29	1.3k 1.1×	618 0.6×	621 0.7×	876 1.2×	565 0.8×	177	2.9k
Ja June Jang South Korea	33	1.7k 1.6×	752 0.7×	887 1.0×	741 1.0×	749 1.0×	94	3.6k
Wei‐Fen Xie China	38	2.1k 1.8×	1.0k 1.0×	905 1.0×	999 1.3×	1.2k 1.7×	116	4.3k
Hideyuki Miyoshi Japan	26	1.4k 1.3×	1.9k 1.8×	794 0.9×	345 0.5×	1.4k 2.0×	49	3.9k
Le‐Xing Yu China	22	2.2k 2.0×	825 0.8×	1.1k 1.2×	1.2k 1.6×	734 1.0×	27	3.9k

Countries citing papers authored by Hisanobu Ogata

Since Specialization

Citations

This map shows the geographic impact of Hisanobu Ogata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisanobu Ogata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisanobu Ogata more than expected).

Fields of papers citing papers by Hisanobu Ogata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisanobu Ogata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisanobu Ogata. The network helps show where Hisanobu Ogata may publish in the future.

Co-authorship network of co-authors of Hisanobu Ogata

This figure shows the co-authorship network connecting the top 25 collaborators of Hisanobu Ogata. A scholar is included among the top collaborators of Hisanobu Ogata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisanobu Ogata. Hisanobu Ogata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ogata, Hisanobu, Akira Imaizumi, Yutaka Fujioka, et al.. (2024). A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts. Anticancer Research. 44(12). 5215–5218. 1 indexed citations

Onishi, Hideya, Kosuke Yanai, Masayo Umebayashi, et al.. (2018). RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer. Anticancer Research. 38(8). 4543–4547. 12 indexed citations

Ogata, Hisanobu, Toshihiko Okazaki, Kazunari Yamada, et al.. (2018). Investigator initiated clinical trial of cancer vaccine OCV-C01 in advanced and recurrent biliary tract cancer. Annals of Oncology. 29. vii60–vii60. 1 indexed citations

Ogata, Hisanobu, Hideko Noguchi, Toshio Ohtsubo, et al.. (2016). Angiotensin II type I receptor blocker, Losartan, inhibits fibrosis in liver by suppressing TGF-beta1 production. Integrative Molecular Medicine. 3(1). 5 indexed citations

Nakagawa, Hayato, Atsushi Umemura, Koji Taniguchi, et al.. (2014). ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development. Cancer Cell. 26(3). 331–343. 396 indexed citations breakdown →

Hatziapostolou, Maria, Christos Polytarchou, Eleni Aggelidou, et al.. (2013). An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. Cell. 152(5). 1196–1196. 1 indexed citations

He, Guobin, Debanjan Dhar, Hayato Nakagawa, et al.. (2013). Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling. Cell. 155(2). 384–396. 358 indexed citations

Hatziapostolou, Maria, Christos Polytarchou, Eleni Aggelidou, et al.. (2011). An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis. Cell. 147(6). 1233–1247. 375 indexed citations

He, Guobin, Guann‐Yi Yu, Vladislav Temkin, et al.. (2010). Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation. Cancer Cell. 17(3). 286–297. 359 indexed citations

10.

Takahashi, Hiroyuki, Hisanobu Ogata, Reiko Nishigaki, David H. Broide, & Michael Karin. (2010). Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ- and JNK1-Dependent Inflammation. Cancer Cell. 17(1). 89–97. 348 indexed citations

11.

Ogata, Hisanobu, et al.. (2010). Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet. Liver International. 30(8). 1229–1239. 33 indexed citations

12.

Yan, Jim, Raymond Ng, Hisanobu Ogata, et al.. (2009). Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. Journal of Lipid Research. 50(10). 2072–2082. 77 indexed citations

13.

Ogata, Hisanobu, Takashi Kobayashi, Takatoshi Chinen, et al.. (2006). Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced Hepatocarcinogenesis. Gastroenterology. 131(1). 179–193. 153 indexed citations

14.

Chinen, Takatoshi, Takashi Kobayashi, Hisanobu Ogata, et al.. (2006). Suppressor of Cytokine Signaling-1 Regulates Inflammatory Bowel Disease in Which Both IFNγ and IL-4 Are Involved. Gastroenterology. 130(2). 373–388. 76 indexed citations

15.

Takeda, Atsunobu, Shinjiro Hamano, Hiroshi Shiraishi, et al.. (2005). WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation. International Immunology. 17(7). 889–897. 21 indexed citations

16.

Yoshida, Takafumi, Hisanobu Ogata, Tsutomu Douchi, et al.. (2004). SOC1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene. 23(17). 3107–3115. 63 indexed citations

17.

Yoshida, Takafumi, Hisanobu Ogata, Akiko Joo, et al.. (2004). SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis. The Journal of Experimental Medicine. 199(12). 1701–1707. 155 indexed citations

18.

Kawaguchi, Takumi, Takafumi Yoshida, Masaru Harada, et al.. (2004). Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3. American Journal Of Pathology. 165(5). 1499–1508. 452 indexed citations

19.

Ogata, Hisanobu, et al.. (1998). Crescentic Glomerulonephritis due to Rifampin Treatment in a Patient with Pulmonary Atypical Mycobacteriosis. The Nephron journals/Nephron journals. 78(3). 319–322. 20 indexed citations

20.

Ogata, Hisanobu, et al.. (1997). Fatty liver in a case with heterozygous familial hypobetalipoproteinemia.. PubMed. 92(2). 339–42. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact